Filippo Marino et al. 2023. Mirabegron, a First-in-class Non-antimuscarinic Drug for the Overactive Bladder. Novel Research Aspects in Medicine and Medical Science Vol. 8. (Oct. 2023), 48–67. DOI:https://doi.org/10.9734/bpi/nramms/v8/9482F.